← Evidence map

ArticleNeuro-oncology advances

Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.

Kristyn Galbraith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2024
2025
2026
pooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37476329